Atlas Trials

Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease

Clinical trial NCT02066571 · UNKNOWN

Trial details

NCT number
NCT02066571
Sponsor
Henry Ford Health System
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's DiseaseFreezing of GaitCognitive Ability, General
Start date
2015-03-01
Primary completion
2017-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.